updated 6/15/2011 7:16:37 AM ET 2011-06-15T11:16:37

DALLAS, June 15, 2011 (GLOBE NEWSWIRE) -- MicroStockProfit.com announces an investment report featuring K-V Pharmaceutical Co. (NYSE:KV-A). The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

The full report is available at: www.microstockprofit.com/lp/KV-A

K-V Pharmaceutical Co. (KV-A) is a fully integrated specialty pharmaceutical company that develops, manufactures, acquires and markets technologically-distinguished branded and generic/non-branded prescription pharmaceutical products. Its strategic goal is to become a specialty branded pharmaceutical marketing company primarily focused on women's healthcare. The Company conducts its branded pharmaceutical operations through Ther-Rx and, previously, it conducted its generic/non-branded pharmaceutical operations through ETHEX, which focused principally on technologically-distinguished generic products. In May 2010, the Company formed a wholly-owned subsidiary, Nesher, to operate as the sales and marketing company for its generic products. The Company expects to complete a divestiture of Nesher and the Company's generics business by the end of calendar year 2011.

This newsletter has been helping traders make great investment decisions on KV-A; click here for a 25% discount offer.

In the report, the analyst notes:

"Shares of KV-A dropped more than 22% to close Tuesday at $2.52, a day after the drug developer announced the filing of its form 10-K for its fiscal year ended March 31, 2010, with the Securities and Exchange Commission. About 3.99 million shares have traded hands during the session, versus the 10-day average volume of 1.86 million.

"KV-A reported an increase of $18.2 million in net revenues for the fiscal year ended March 31, 2011, a 200.2% improvement over the previous year. The Company attributed the increase to $13.7 million of net revenues recorded in fiscal year 2011 related to the initial launch of Makena."

To read the entire report visit: www.microstockprofit.com/lp/KV-A

See what investors are saying about KV-A at http://www.stockhideout.com

Get breaking news on KV-A at http://thestockmarketwatch.com/

MicroStockProfit.com is a small-cap research and investment commentary provider. MicroStockProfit.com strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on MicroStockProfit please visit: http://www.microstockprofit.com

MicroStockProfit.com Disclosure

MicroStockProfit.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. MicroStockProfit.com is a Web site wholly owned by BlueWave Advisors, LLC. Neither MicroStockProfit.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. Please read our report and visit our Web site, MicroStockProfit.com, for complete risks and disclosures.

CONTACT: Jay Geller

© Copyright 2012, GlobeNewswire, Inc. All Rights Reserved


Discussion comments


Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments

Data: Latest rates in the US

Home equity rates View rates in your area
Home equity type Today +/- Chart
$30K HELOC FICO 3.79%
$30K home equity loan FICO 4.99%
$75K home equity loan FICO 4.69%
Credit card rates View more rates
Card type Today +/- Last Week
Low Interest Cards 13.83%
Cash Back Cards 17.80%
Rewards Cards 17.18%
Source: Bankrate.com